Streetbeat News

Regulatory

AVAV

FXI

SPY

UAVS

VISL

China's Commerce Ministry has announced export controls on drone-related equipment, effective from September 1. This move comes amid ongoing tech tensions between China and the US.

Portfolio Pulse from Charles Gross

July 31, 2023 | 10:14 am

CTXR

Citius Pharmaceuticals received a Complete Response Letter from the FDA for Lymphir (Denileukin Diftitox) for relapsed/refractory cutaneous T-cell lymphoma, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 9:39 am

NAVB

Navidea Biopharmaceuticals has announced that the NYSE American has started delisting proceedings against the company. Navidea intends to appeal against this decision. This news has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 9:37 am

VGK

The Eurozone Consumer Price Index (CPI) for July was reported at 5.3%, in line with estimates but slightly lower than the previous month's 5.5%.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 9:07 am

VGK

The Eurozone Consumer Price Index (CPI) has shown a preliminary month-on-month decrease of 0.1%, which is lower than the estimated 0.3% and the prior 0.3%.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 9:05 am

VGK

The Consumer Price Index (CPI) in the Eurozone for June has matched the estimated 5.3%, which is a slight decrease from 5.5% in May.

Portfolio Pulse from Charles Gross

July 31, 2023 | 9:04 am

VGK

The Eurozone Core Consumer Price Index (CPI) preliminary year-on-year (YoY) has been reported at 5.5%, which is slightly higher than the estimated 5.4% and equal to the prior figure of 5.5%.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 9:03 am

IMMP

MRK

Immutep Limited announced that its TACTI-002 Phase II trial data for the treatment of 1st line non-small cell lung cancer has been accepted for presentation at the 2023 European Society for Medical Oncology Congress. The data pertains to the combination of eftilagimod alpha and KEYTRUDA, Merck & Co.'s anti-PD-1 therapy.

Portfolio Pulse from Charles Gross

July 31, 2023 | 8:48 am

NAVB

Navidea Biopharmaceuticals has received a written notification from the NYSE that it intends to commence proceedings to delist the company's stock. The company's board plans to appeal this decision.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 8:07 am

FXI

TM

Toyota Motor Corp (TM) plans to boost its electric vehicle (EV) development and technology in China, according to Reuters. The move is part of Toyota's strategy to meet China's stringent green car quotas and its broader global shift towards EVs.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 7:38 am